Journal of Alzheimer s Disease 2018

15 papers
In 2018, the Journal of Alzheimer’s Disease featured research focused on enhancing diagnostic precision and identifying physiological markers of cognitive impairment. A primary theme involved the application of neuroimaging and electrophysiological tools, such as web-based whole-brain volumetry, EEG theta power, and diffusion-weighted MRI for structural connectome evaluation. Studies also investigated the correlation between regional white matter hyperintensity and grey matter atrophy, alongside epidemiological research into the effects of homocysteine on cerebral atrophy. Experimental work during this period included the characterization of motor neurodegenerative phenotypes in amyloid-beta mouse models and the preclinical evaluation of all-D-enantiomeric peptides for potential treatment. Additionally, the journal explored the integration of systems biology and neurophysiology into precision neurology. Notable contributors to the year's publications included Antje Willuweit, Dieter Willbold, and Christopher Li Hsian Chen. This body of work reflects a trend toward multi-modal diagnostic validation and the exploration of biochemical pathways influencing neurodegeneration.

Top Research Directions

The 3 research directions with Journal of Alzheimer s Disease 2018 papers, ranked by paper count, next to 2017. Share is the fraction of the edition’s papers in the direction.

#Direction20182017Share 2018Share 20172017 rank
1Overcoming the Blood Brain Barrier for CNS Drug Delivery106.7%0.0%—
2Quantifying the Biophysical Integrity of Cellular Barriers106.7%0.0%—
3The Biophysical Mechanisms of Protein Oligomer Toxicity106.7%0.0%—

Download all directions as CSV

Institutions

Institutions credited by Journal of Alzheimer s Disease 2018 papers: a paper credits every institution named in its affiliations, once. 3 institutions share 1 credited papers.

#InstitutionPapersShare20172017 rank
1Forschungszentrum Jülich 1100.0%0—
2Heinrich Heine University Düsseldorf 1100.0%0—
3RWTH Aachen University 1100.0%0—

Download all institutions as CSV

About this data

Papers. Journal of Alzheimer s Disease 2018 lists 15 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers. Comparisons with 2017 use shares, since the edition went from 8 to 15 papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 15 papers (6.7%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Journal of Alzheimer s Disease 2018”, https://lacuna.tiptreesystems.com/venue/journal-of-alzheimer-s-disease/2018.

Top Authors

AuthorPapers
Christopher Li Hsian Chen2
N. Jon Shah2
Cuntai Guan1
Hongzhi Wang1
Hugo Kuijf1

Papers

Title
Assessment of the Mid-Life Demographic and Lifestyle Risk Factors of Dementia Using Data from the Framingham Heart Study Offspring Cohort
Automated Multi-Atlas Segmentation of Hippocampal and Extrahippocampal Subregions in Alzheimer’s Disease at 3T and 7T: What Atlas Composition Works Best?
Challenges for Optimizing Real-World Evidence in Alzheimer’s Disease: The ROADMAP Project
Comprehensive Characterization of the Pyroglutamate Amyloid-β Induced Motor Neurodegenerative Phenotype of TBA2.1 Mice
EEG Theta Power Is an Early Marker of Cognitive Decline in Dementia due to Alzheimer’s Disease
Effectiveness of a Personalized Brain-Computer Interface System for Cognitive Training in Healthy Elderly: A Randomized Controlled Trial
Homocysteine and Cerebral Atrophy: The Epidemiology of Dementia in Singapore Study
Increasing Diagnostic Accuracy of Mild Cognitive Impairment due to Alzheimer’s Disease by User-Independent, Web-Based Whole-Brain Volumetry
In Vitro Potency and Preclinical Pharmacokinetic Comparison of All-D-Enantiomeric Peptides Developed for the Treatment of Alzheimer’s Disease
In Vitro Potency and Preclinical Pharmacokinetic Comparison of All-D-Enantiomeric Peptides Developed for the Treatment of Alzheimer’s Disease
Low Accuracy of Brief Cognitive Tests in Tracking Longitudinal Cognitive Decline in an Asian Elderly Cohort
Regional White Matter Hyperintensity Influences Grey Matter Atrophy in Mild Cognitive Impairment
Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology
Targeting Alzheimer’s Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment
The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation